Marie Viala
Montpellier, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Antacid co-treatment and pregnane X receptor genetic polymorphisms are survival determinants in patients treated with palbociclib.
Journal: Breast cancer research and treatment
Published: March 31, 2026
Early non-compliance with oral anticancer drugs, a clinical pharmacy as key issue in onco-senology
Journal: Therapie
Published: August 22, 2024
Modernizing the assessment and reporting of adverse events in oncology clinical trials using complementary statistical approaches: a case study of the MOTIVATE trial.
Journal: Investigational new drugs
Published: June 07, 2024
Circulating tumour cells and PD-L1-positive small extracellular vesicles: the liquid biopsy combination for prognostic information in patients with metastatic non-small cell lung cancer.
Journal: British journal of cancer
Published: March 17, 2023
Pharmacokinetic Variability Drives Palbociclib-Induced Neutropenia in Metastatic Breast Cancer Patients: Drug-Drug Interactions Are the Usual Suspects.
Journal: Pharmaceutics
Published: March 08, 2022
Oral targeted therapy dose adaptation in older patients with cancer: A real-life French cohort.
Journal: British journal of clinical pharmacology
Published: July 12, 2021
Programmed Cell Death Ligand 1-Expressing Circulating Tumor Cells: A New Prognostic Biomarker in Non-Small Cell Lung Cancer.
Journal: Clinical chemistry
Published: February 22, 2021
Therapeutic Bayesian monitoring of sunitinib in two patients with impaired absorption or elimination.
Journal: Journal of clinical pharmacy and therapeutics
Published: February 12, 2021
Last Updated: 09/26/2026